GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lumibird LBIRD.PA · EUR

Information Technology · Euronext Paris · 🇫🇷 France

Compare

24.85

+5.07%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Lumibird

Its shares trade on Euronext Paris under the ticker LBIRD.PA. It has been listed since 30 September 1997. In the fiscal year to 31 December 2025, it reported revenue of €228.5m and net income of €14.0m. At that date it held total assets of €428.9m and shareholders' equity of €206.3m.

Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Listed since
30 Sept 1997
Employees
590

Leadership

Pay as last reported

  • Mr. Marc Le FlohicChairman of the Board, Chief Executive Officer, Founder, since 2016€720,401
  • Ms. Sonia RutnamChief Financial and Transformation Officer, General Secretary
  • Mr. Nicolas BallifChief Human Resources Officer
  • Mr. Jean-Marc GendreGeneral Manager - Medical Division, since 2022€470,646
  • Mr. Alexandre BillardDirector - Purchasing & Photonics Division, since 2024
  • Mr. Jean-Francois CoutrisDirector, Representative of ESIRA€7,000
  • Mr. Ajit JayaratnamDirector (Non Voting Member), since 2020
  • Ms. Gwenaelle Le FlohicDirector€7,000
  • Mr. Etienne De LasteyrieIndependent Director
  • Ms. Marie Begona LebrunIndependent Director€7,000
  • Ms. Marie-Helene SergentIndependent Director
  • Mr. Mathieu CalleuxIR Contact Officer, since 2022

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Lumibird SA possesses several strengths that contribute to its success in the market.

Weaknesses

  • Despite its strengths, Lumibird SA also faces a few weaknesses that could hinder its growth.

Opportunities

  • Lumibird SA can leverage the following opportunities to expand its market presence.

Threats

  • Lumibird SA needs to address the following threats to mitigate potential risks.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.